Navigation Links
Neuroimaging study: Negative messages less effective on those who are substance dependent
Date:11/25/2012

BLOOMINGTON, Ind. -- What types of public messages will most likely deter drug and alcohol abuse or dissuade people from engaging in risky behavior? Negatively framed messages may not be an effective way to reach those most in need of persuasion, suggests a new study in Psychology of Addictive Behaviors by researchers from Indiana University and Wayne State University.

"The findings are somewhat ironic because a whole lot of public service announcements say, 'Drugs are bad for you,' 'Just say no,' or 'This is your brain on drugs' with an image of an egg frying," said principal investigator Joshua Brown, associate professor in the Department of Psychological and Brain Sciences in IU Bloomington's College of Arts and Sciences. "What we're seeing is that negative messages are not having the same impact on the brain."

Using neuroimaging techniques, the researchers examined the impact of different messages on the brains of substance-dependent individuals and compared them to their effects on non-substance-dependent individuals. They also sought to determine where the problem lies in the circuit between message, brain and behavior, where the signal goes wrong. Is it in the relationship between brain activity and behavior or in the impact of the message on the brain? Perhaps the brains of substance-dependent people are sensitive to risk, but the knowledge does not guide their behavior. Or perhaps substance-dependent people perceive messages differently in the first place.

To answer these questions, participants took part in a virtual game, the Iowa Gambling Task, often used in psychological studies on decision-making. Four decks of cards appear on a screen, and the participants were told they will either win or lose money by choosing certain decks. The substance-dependent group showed less brain activity in response to the negatively framed message that a certain deck would lead to losses. The negative messages also led to significantly worse, riskier decisions in the substance-dependent group than in the non-user group.

The findings suggest that the level of brain activity in regions of the brain that assess risk is lower in substance-dependent individuals than those who are not drug- or alcohol-dependent. These two groups process the messages differently, particularly those messages that emphasize loss or reduced prospects for gain.

The research contributes to a growing body of health communication literature that examines the impact of particular types of messages on the neural mechanisms involved in making risky decisions. It also contributes to a larger story about the regions of the brain that are activated in response to risk and danger. One particular region, the anterior cingulate cortex, is heavily involved in a variety of clinical disorders including drug abuse, ADHD, autism, schizophrenia and obsessive-compulsive disorder.

At stake, Brown notes, are hundreds of billions in health care costs and lost productivity, as well as questions about public policy and how best to discourage drug abuse.

"The government spends millions every year trying to discourage drug use, and a lot of the ads highlight the dangers of drugs," he said. "Should we spend more to highlight the benefits of staying clean instead?"

Brown said they can't yet say whether positive messages are more effective at reducing drug use because their experiment involved decisions about money rather than drugs. They are working on it, though, and have just started to look at how people make decisions with respect to drugs.


'/>"/>
Contact: Liz Rosdeitcher
rosdeitc@indiana.edu
812-855-4507
Indiana University
Source:Eurekalert  

Related medicine news :

1. Study: Women not getting enough exercise; at risk of developing metabolic syndrome
2. Study: Insomnia takes toll on tinnitus patients
3. Study: No link between depression, nasal obstruction
4. Study: More Pre-Teens Get Vaccines When Middle Schools Require Them
5. Study: Kids Who Sleep in Parents Bed Less Likely to Be Overweight
6. OHSU study: Misdiagnosis of MS is costing health system millions per year
7. UW study: Sleep apnea associated with higher mortality from cancer
8. Study: Heart damage after chemo linked to stress in cardiac cells
9. STeleR study: Telerehab improves functioning after stroke
10. Study: Willingness to be screened for dementia varies by age but not by sex, race or income
11. Study: 21 percent of newly admitted nursing home residents sustain a fall during their stay
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Neuroimaging study: Negative messages less effective on those who are substance dependent
(Date:9/22/2017)... ... 22, 2017 , ... Egg freezing and embryo freezing are ... a slight statistical advantage for live births, frozen eggs offer many advantages, depending ... undergoing medical treatment or who are concerned about the decline of their fertility ...
(Date:9/21/2017)... ... September 21, 2017 , ... 38-Year-Old Plastic Surgeon Gill at Aesthetic Surgery ... is pleased to announce that Plastic Surgeon Kiranjeet Gill has been awarded as one ... is an annual award that was started in 2003 to salute young achievers in ...
(Date:9/21/2017)... ... September 21, 2017 , ... The American Addiction ... Services for professionals in the addiction treatment industry entitled: Special Investigations Unit ... Insurance companies and state and federal governments are increasingly scrutinizing the addiction treatment ...
(Date:9/21/2017)... ... 21, 2017 , ... Demonstrating a consistent and continued commitment ... been awarded five-year accreditation status through the Public Health Accreditation Board ... by a PHAB-accredited health department now extend to more than 203 million people, ...
(Date:9/21/2017)... (PRWEB) , ... September 21, 2017 , ... ... using Microscan’s LVS 7510 at the Global GS1 Healthcare Conference 2017 in Chicago, ... the life-sciences industry for ensuring label quality and improving patient safety. , ...
Breaking Medicine News(10 mins):
(Date:9/19/2017)... Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses ... today:   ... Jim ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and business ...
(Date:9/12/2017)... , Sept. 12, 2017   EcoVadis , the leading platform for ... the first annual edition of its Global CSR Risk and Performance Index. ... by EcoVadis, based on Scorecard Ratings that analyzed nearly 800,000 data points ... ... ...
(Date:9/9/2017)...  Eli Lilly and Company (NYSE: LLY ... for lasmiditan, an investigational, oral, first-in-class molecule for the ... compared to placebo in the Phase 3 SPARTAN study. ... Congress of the International Headache Society (IHC) in ... today demonstrate lasmiditan,s potential to reduce pain and provide ...
Breaking Medicine Technology: